Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
Open Access
- 20 April 2021
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-11
Abstract
Background. Circulating plasma mRNAs can be analyzed to identify putative cancer biomarkers. This study was conducted in an effort to detect plasma mRNA biomarkers capable of predicting pancreatic cancer (PACA) patient prognosis. Material and Methods. First, prognostic mRNAs that were differentially expressed in PACA in The Cancer Genome Atlas (TCGA) were established, after which microarray expression profiles from PACA patient plasma samples were utilized to specifically identify potential prognostic plasma mRNA biomarkers associated with this cancer type. In total, plasma samples were then collected from 79 PACA patients and 19 healthy controls to confirm differential mRNA expression via qPCR, while Kaplan–Meier analyses were used to examine the link between mRNA expression and patient overall survival. Results. In total, three prognostic differentially expressed genes were identified in PACA patient plasma samples, including SMAP2, PTPN6, and EVL (Ena/VASP-like). Plasma EVL levels were confirmed via qPCR to be correlated with tumor pathology , while the overall survival of patients with low plasma EVL levels was poor . Multivariate Cox regression analyses further confirmed that plasma EVL levels were independent predictors of PACA patient prognosis. Conclusion. We found that PACA is associated with the downregulation of plasma EVL mRNA levels, indicating that this mRNA may be a viable biomarker associated with patient prognosis.Keywords
Funding Information
- National Natural Science Foundation of China (81772516)
This publication has 26 references indexed in Scilit:
- Circulating RNAs as new biomarkers for detecting pancreatic cancerWorld Journal of Gastroenterology, 2015
- Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for lung cancer: A marker phase I trialThoracic Cancer, 2014
- miR‐342‐3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancerFEBS Letters, 2014
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Differential Remodeling of Actin Cytoskeleton Architecture by Profilin Isoforms Leads to Distinct Effects on Cell Migration and InvasionCancer Cell, 2012
- Identification of Serum Biomarker Signatures Associated with Pancreatic CancerCancer Research, 2012
- Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer.2010
- Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancerOncogene, 2008
- Spectrin interacts with EVL (Enabled/vasodilator‐stimulated phosphoprotein‐like protein), a protein involved in actin polymerizationBiology of the Cell, 2006
- Ena/VASP Proteins: Regulators of the Actin Cytoskeleton and Cell MigrationAnnual Review of Cell and Developmental Biology, 2003